Gift will support advancement of multi-disciplinary comprehensive care strategy for AHN's growing memory disorders programs

PITTSBURGH, Sept. 28, 2026 /PRNewswire/ -- Allegheny Health Network (AHN) is pleased to announce a $1 million commitment from Greg and Ellen Jordan to the network's Department of Neurology, supporting memory disorder research, education and expanded care.

The Greg and Ellen Jordan Endowed Professorship for Alzheimer's Disease and Related Disorders (ADRD), will expand AHN's efforts to advance innovative clinical care, neuroscience research, and support programming for patients living with Alzheimer's disease and other forms of dementia and cognitive impairment. Aligned with community needs, this investment will also help patients live their best lives by increasing access to comprehensive wrap-around services designed to support patients and their loved ones holistically, and beyond traditional medicine.

Greg Jordan is chairman of the Board of Directors of Highmark Health, a position he has held since 2025. He also serves on the Board of Directors of MSA Safety and is vice chairman of PNC. He previously served as PNC's general counsel and chief administrative officer; he retired from those roles in 2024.

"For Ellen and me, supporting Alzheimer's and memory care research is personal," Jordan said. "We have each lost a parent to memory-related diseases, and we know that supporting AHN's research in this field is needed to continue to make progress on finding ways to deal with these challenges."

The gift will also help strengthen AHN's broader investment in memory disorder care, including the enhancement of the Memory Disorders Clinic at AHN West Penn Hospital. The clinic currently serves approximately 2,000 patients annually and provides comprehensive care that considers not only patients' neurological needs, but also caregiver demands, behavioral health needs, social determinants of health, and advance-care planning.

"Greg and Ellen Jordan's extraordinary generosity will help us build upon the strength of our memory disorders program and position AHN to meet the growing needs of patients and their families affected by cognitive disorders," said Stephen Samples, MD, chair of the Department of Neurology at AHN. "This investment gives us the ability to advance patient care while also fostering research, education and innovation. We are deeply grateful to the Jordans for this investment in the future of neurological care in our region."

One similar project already underway is the new hub for the AHN Neuroscience Department.

The five-story hub at Allegheny General Hospital serves as an anchor for AHN's broader, network-wide approach to neurological care, connecting patients and clinicians across a continuum of specialized services and locations. The new model brings together expertise across disciplines and sites to support coordinated care, advanced diagnostics and therapies, research, education and innovation for patients with complex neurological conditions.

The continued development of the Memory Disorders Clinic at West Penn Hospital is an important part of that broader strategy, expanding access to specialized cognitive and memory care while connecting patients and families to the depth of expertise and resources available throughout AHN's Neuroscience Department.

Space enhancements for the Memory Disorders Clinic at West Penn will provide a calming, patient- and family-centered environment where memory neurologists, nurse navigators, geriatricians, pharmacists, dietitians and other multidisciplinary clinicians can collaborate in the diagnosis and treatment of memory disorders.

The clinic's expansion comes at a time when the need for comprehensive memory care continues to grow, regionally and nationally. AHN has implemented innovative programs such as the Aging Brain Care Program, which provides comprehensive coaching and support for caregivers, and participates in the Centers for Medicare and Medicaid Services' Guiding an Improved Dementia Experience (GUIDE) model.

The number of Americans living with Alzheimer's disease and related forms of dementias is projected to reach 8.5 million by 2030, and 14 million by 2060.

"Investments like this are essential to advancing our mission of providing remarkable health care experiences for patients and families throughout Western Pennsylvania," said Mark Sevco, president, AHN. "The Jordan family's generosity will help AHN strengthen a program that is addressing one of the most significant health challenges facing our aging population. We are incredibly grateful for their commitment to helping shape the future of memory disorders care."

Through the Jordan family's generosity, AHN will be better positioned to advance prevention and early detection — key pillars of AHN's and Highmark Health's "Living Heath" clinical model. Living Health is an integrated, "whole person" care and coverage strategy that gets ahead of costly chronic conditions and diseases by focusing on physical, mental, and social health at the population level instead of just treating individual illnesses.

 About Allegheny Health Network

Allegheny Health Network (AHN.org) is an integrated health care delivery system serving the greater Western Pennsylvania region. The network is composed of 16 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home- and community-based health services, a research institute, and a group purchasing organization. AHN provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, cardiovascular disease, cancer care, orthopedic surgery, neurology and neurosurgery, women's health, diabetes and more. AHN employs approximately 27,000 people, has 3,000 physicians on its medical staff, and serves as a clinical campus for Drexel University College of Medicine, Lake Erie College of Osteopathic Medicine and Duquesne University College of Osteopathic Medicine.

Media Contact: Sarafina James, [email protected]

SOURCE Allegheny Health Network

Share this article

PASADENA, Calif., Sept. 28, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced the closing of its amended and restated $5.0 billion unsecured senior line of credit, a strategic extension that further strengthens the company's long-term financial flexibility and reflects the enduring support of its longstanding, trusted banking partners. The amendment extends the maturity of the facility to January 2032 and reduces the applicable borrowing margin, reinforcing Alexandria's disciplined and proactive management of its strong and flexible balance sheet. The amended agreement became effective on September 24, 2026.

The amended agreement extends the maturity date of Alexandria's $5.0 billion unsecured senior line of credit from January 22, 2030 to January 22, 2032, assuming the company exercises its rights to extend the maturity date twice by an additional six months for each exercise, subject to certain conditions. The extension preserves Alexandria's substantial revolving credit capacity and advances the company's longstanding financial strategy to maintain significant liquidity, prudently ladder debt maturities, and preserves access to diverse sources of capital, providing critical financial capacity to execute across market cycles.

The amended agreement also reduces the applicable borrowing rate to SOFR plus 0.725%, representing an 11-basis-point reduction from the currently applicable rate of SOFR plus 0.835%.

"The successful extension of our $5.0 billion unsecured senior line of credit underscores the strength of our mission-critical relationships with our banking partners and their continued confidence in and longstanding support of Alexandria," said Marc E. Binda, chief financial officer and treasurer of Alexandria Real Estate Equities, Inc. "Extending the maturity to 2032 while reducing our borrowing margin represents another consequential execution by our best-in-class team to further strengthen our balance sheet, prudently manage our long-term cost of capital, and maintain significant liquidity and financial flexibility. These enduring financial strengths position Alexandria to execute our highly differentiated, mission-driven business model with discipline and conviction, and capitalize on strategic opportunities through evolving market cycles."

Citibank, N.A. serves as administrative agent under the amended agreement. Citibank, N.A., BofA Securities, Inc., JPMorgan Chase Bank, N.A., Goldman Sachs Bank USA, RBC Capital Markets, Banco Bilbao Vizcaya Argentaria, S.A. New York Branch, Mizuho Bank, Ltd., Sumitomo Mitsui Banking Corporation, TD Bank, N.A., The Bank of Nova Scotia, Truist Securities, Inc. and U.S. Bank National Association serve as joint lead arrangers; and Citibank, N.A., BofA Securities, Inc., JPMorgan Chase Bank, N.A., Goldman Sachs Bank USA and RBC Capital Markets serve as joint bookrunners.

About Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science and advanced technology innovation cluster locations, including Greater Boston, San Diego, the San Francisco Bay Area, Seattle, Maryland, Research Triangle and New York City. For more information, please visit www.are.com.

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding Alexandria's corporate responsibility initiatives, strategic investments, partnerships and support of charitable and community organizations; Alexandria's role in supporting tenants and companies in which it invests that are engaged in research and development in hematology and oncology; and the anticipated impact or benefits of these investments, partnerships and support, including the expected impact of the missions, programs and initiatives of the charitable and community organizations Alexandria supports. These forward-looking statements are based on Alexandria's present intent, beliefs, or expectations, but forward-looking statements are not guaranteed to occur and may not occur. Actual results may differ materially from those contained in or implied by Alexandria's forward-looking statements as a result of a variety of factors, including, without limitation, the risks and uncertainties detailed in its filings with the Securities and Exchange Commission. All forward-looking statements are made as of the date of this press release, and Alexandria assumes no obligation to update this information. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in Alexandria's forward-looking statements, and risks and uncertainties to Alexandria's business in general, please refer to Alexandria's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and any subsequently filed quarterly reports on Form 10-Q.

CONTACT: Sara Cohen, Assistant Vice President – Capital Markets & Corporate Operations, (646) 799-2617, [email protected]

SOURCE Alexandria Real Estate Equities, Inc.

Share this article

Gross Proceeds to Viking Approximately $575 Million

SAN DIEGO, Sept. 28, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the closing of its concurrent upsized public offerings of 9,035,714 shares of common stock, at a public offering price of $35.00 per share, and $258.75 million aggregate principal amount of 2.00% convertible senior notes due 2032 (the "notes"), which included the full exercise by the underwriters of the common stock offering of their option to purchase an additional 1,178,571 shares of common stock, and the full exercise by the underwriters of the note offering of their option to purchase an additional $33.75 million aggregate principal amount of notes. The gross proceeds to Viking from the offerings were approximately $575.0 million, before deducting underwriting discounts and commissions and offerings expenses.

Morgan Stanley, J.P. Morgan, Jefferies, Leerink Partners and William Blair acted as joint book-running managers for the note offering. Morgan Stanley, J.P. Morgan, Jefferies, Leerink Partners, William Blair and Raymond James acted as joint book-running managers for the common stock offering. Oppenheimer & Co. acted as lead manager and Canaccord Genuity, H.C. Wainwright & Co., B. Riley Securities, Maxim Group LLC and Laidlaw & Company (U.K.) Ltd. acted as co-managers for the common stock offering.

Viking estimates that the aggregate net proceeds from the offerings were approximately $547.8 million, after deducting the underwriting discounts and commissions and Viking's estimated offering expenses. Viking intends to use the net proceeds from the offerings for the continued clinical development, advancement and commercialization of its VK2735 program, the continued clinical development and advancement of its VK3019 program and for other general research and development, working capital and general corporate purposes.

The offerings were made pursuant to an effective shelf registration statement on file with the Securities and Exchange Commission (the "SEC"). Each offering was made only by means of a prospectus supplement relating to that offering and an accompanying prospectus. An electronic copy of the final prospectus supplement for each offering, together with the accompanying prospectus, is available on the SEC's website at www.sec.gov. Alternatively, copies of these documents can be obtained by contacting: Morgan Stanley & Co. LLC at 180 Varick Street, 2nd Floor, New York, New York 10014, Attention: Prospectus Department; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at [email protected] and [email protected].

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any securities referred to in this press release, nor will there be any sale of any such securities, in any state or other jurisdiction in which such offer, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Viking Therapeutics, Inc.

Viking Therapeutics, Inc. is a clinical-stage biotechnology company advancing a next-generation portfolio of therapies for obesity and metabolic disease. Guided by deep expertise in metabolic biology and rigorous science, Viking is developing innovative treatments to help people achieve meaningful, lasting health improvements by treating obesity first. The company's lead program, VK2735, is a dual glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist in development in both subcutaneous and oral formulations for obesity. VK2735 is currently being evaluated in Phase 3 clinical studies for obesity, along with maintenance dosing strategies designed to support long-term weight management. Viking is also advancing additional obesity programs, including VK3019, an amylin receptor agonist, VK2809, an orally available thyroid hormone receptor beta agonist for metabolic and liver disease, and VK0214 for the rare genetic disorder X-linked adrenoleukodystrophy (X-ALD).

Forward-Looking Statements

This press release contains forward-looking statements regarding Viking Therapeutics, Inc., under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements about the expected amount and intended use of the net proceeds. Forward-looking statements represent Viking's current expectations regarding future events and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those implied by the forward-looking statements. Among those risks and uncertainties are risks described under the caption "Risk Factors" in the final prospectus supplements for the offerings and risks relating to Viking's business, including those described in Viking's most recent periodic reports filed with the Securities and Exchange Commission, including Viking's Annual Report on Form 10-K for the year ended December 31, 2025, and subsequent Quarterly Reports on Form 10-Q, including the risk factors set forth in those filings. The forward-looking statements included in this press release speak only as of the date of this press release, and Viking does not undertake to update the statements included in this press release for subsequent developments, except as may be required by law.

SOURCE Viking Therapeutics, Inc.

Share this article

DENVER, Sept. 28, 2026 /PRNewswire/ -- Gates Industrial Corporation Ltd. (NYSE: GTES), a leading global manufacturer of innovative, highly engineered power transmission and fluid power solutions, today announced it has completed the acquisition of the belts business of The Timken Company, including select manufacturing assets.

The acquisition expands Gates' North American power transmission with additional manufacturing capacity and customer relationships across industrial original equipment manufacturers (OEM), the industrial aftermarket and mobility power sports markets, while also augmenting the company's talent base.

"The completion of this acquisition strengthens Gates' position in power transmission and supports our strategy to grow in industrial and mobility markets," said Tom Pitstick, president, Americas at Gates. "We are pleased to welcome the new team members who are joining Gates and look forward to building on our combined capabilities to create value for our customers, employees and stakeholders."

Gates has developed a structured integration approach and will leverage the broad in-region manufacturing and distribution footprint to support customers through this transition. As part of the transaction, Gates is also assuming operational control of the belts manufacturing facility in San Jose Iturbide, Mexico, enhancing the company's North American footprint.

Financial terms of the transaction were not disclosed.

About Gates Industrial Corporation Ltd. 

Gates is a global manufacturer of innovative, highly engineered power transmission and fluid power solutions. Gates offers a broad portfolio of products to diverse replacement channel customers, and to OEMs as specified components. Gates participates in many sectors of the industrial and consumer markets. Our products play essential roles in a diverse range of applications across a wide variety of end markets ranging from harsh and hazardous industries to everyday consumer applications, including virtually every form of transportation. Our products are sold in more than 130 countries across our three commercial regions: the Americas; Europe, Middle East & Africa; and Asia-Pacific. For more information, visit gates.com.

Forward Looking Statement 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify these forward-looking statements by the use of words such as "outlook," "believes," "expects," "potential," "continues," "may," "will," "should," "could," "seeks," "predicts," "intends," "trends," "plans," "estimates," "anticipates" or the negative version of these words or other comparable words. These statements include, but are not limited to, statements related to the expected benefits of the acquisition and expectations regarding the performance of the Company's business and financial results. Such forward-looking statements are subject to various risks and uncertainties, including, among others, the possibility that the acquisition will not result in the benefits expected by Gates; risks related to the integration of Timken's belts business, including retention of customers and employees; U.S. policies, actions or legislation (including the imposition of tariffs), economic, political and other risks associated with international operations (including as a result of the ongoing conflicts in the Middle East and their impact on supply chains, such as reduced availability of certain of our production materials and increased supply costs, and economic conditions), availability of raw materials or other manufacturing inputs at favorable prices in sufficient quantities, or at a given time, changes in our relationships with, or the financial condition, performance, purchasing power or inventory levels of, of key channel partners, dependence on the continued operation of our manufacturing facilities, supply chains, distribution systems and information technology systems, our ability to forecast demand or meet significant increases in demand and market acceptance of new product introductions and innovations. Additional factors that could cause the Company's results to differ materially from those described in the forward-looking statements can be found under the section entitled "Risk Factors" of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission, as such factors are or may be updated from time to time in the Company's periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in the Company's filings with the SEC. The Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. 

Media Contact

Raquel Fuentes

[email protected]

Investor Contact

Rich Kwas

[email protected]

SOURCE Gates Corporation

Share this article

Second global filing advances rimisoxafen as a novel weed control solution for Brazil's more than 70 million hectares of corn and soybeans

PHILADELPHIA, Sept. 28, 2026 /PRNewswire/ --

FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced the submission of the regulatory dossier for rimisoxafen to Brazilian regulatory authorities. The filing marks the second global regulatory submission for rimisoxafen, the first and only dual mode of action herbicide, following FMC's submission to the U.S. Environmental Protection Agency in July 2026.

Brazil is among the world's largest soybean and corn markets, with approximately 50 million hectares of soybean and over 20 million hectares of corn in production. Growers are facing mounting pressure from resistant broadleaf weeds, including Amaranthus hybridus, which has developed resistance to glyphosate and acetolactate synthase inhibitors, and Amaranthus palmeri, a regulated quarantine weed posing a significant and growing threat to crop productivity.

"Brazilian growers are facing complex weed resistance challenges that demand new and differentiated solutions," said Leonardo Bastos, vice president and chief marketing officer at FMC. "Submitting rimisoxafen for regulatory review in Brazil is an important step forward, demonstrating our long-term commitment to this market and to the growers who depend on innovation to protect their crops and their livelihoods."

Classified by the Herbicide Resistance Action Committee under Groups 12 and 32, rimisoxafen offers growers a novel tool to help diversify weed management programs and support long-term resistance management. In extensive FMC field testing, rimisoxafen has demonstrated consistent activity against small seeded broadleaf weeds and those resistant to other herbicides, including Amaranthus palmeri and Amaranthus hybridus.

Rimisoxafen is the third novel herbicide active ingredient FMC has advanced to regulatory submission in Brazil, following Isoflex™ active and Dodhylex™ active. Together, these submissions reflect the depth and productivity of FMC's research and development pipeline and the company's commitment to advancing next-generation crop protection solutions through the regulatory process.

Formulated product submissions for rimisoxafen are expected to follow as the regulatory process advances in Brazil. Timing and outcomes remain subject to regulatory review and approval. Rimisoxafen is not registered for sale or use in Brazil or any other country. No offer for sale, sale or use of this product is permitted prior to receipt of all required regulatory approvals.

About FMC

FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protecting the environment. FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn®.

Isoflex and Dodhylex are trademarks of FMC Corporation and/or an affiliate. Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions.

Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: FMC and its representatives may from time to time make written or oral statements that are "forward-looking" and provide other than historical information, including statements contained in this press release, in FMC's other filings with the SEC, and in presentations, reports or letters to FMC stockholders.

In some cases, FMC has identified these forward-looking statements by such words or phrases as "outlook", "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2025 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the Securities and Exchange Commission ("SEC"). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement.

We specifically decline to undertake any obligation, and specifically disclaims any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.

SOURCE FMC Corporation

Share this article

Divestiture improves profitability and increases company focus on core areas of expertise

NORTH CANTON, Ohio, Sept. 28, 2026 /PRNewswire/ -- The Timken Company (NYSE: TKR; www.timken.com), a leader in advanced motion technology, today announced the completion of the sale of its belts business assets to Gates Industrial Corporation Ltd. (NYSE: GTES). Financial terms of the transaction were not disclosed.

"This divestiture is an important milestone in achieving our stated 2028 margin targets," said Lucian Boldea, president and chief executive officer. "Exiting the belts business also allows us to increase focus on our core competencies in advanced motion technology."

The divested business manufactures a comprehensive line of belts used in industrial, commercial and consumer applications.

"We believe Gates is the right owner of the business," Boldea said. "Thanks to our belts colleagues for their commitment to Timken and our customers through the years."

The completed divestiture is expected to improve the adjusted EBITDA margins of Timken's Industrial Motion segment and be accretive to EPS in 2027.

Proceeds from the divestiture will help fund Timken's capital allocation priorities.

About The Timken Company

The Timken Company (NYSE: TKR; www.timken.com), a leader in advanced motion technology, designs and manufactures highly engineered systems and components for customers in strategic end markets, including aerospace and defense, power and electrification, and automation and industrial solutions. With more than 125 years of specialized expertise and a multinational presence, Timken is a trusted partner worldwide, innovating and powering performance across the application lifecycle. The company posted $4.6 billion in sales in 2025 and employs approximately 19,000 people, operating from 45 countries. Learn more at www.timken.com or @TheTimkenCompany.

Safe Harbor

Certain statements in this release that are not historical in nature (including the company's forecasts, beliefs, expectations, and targets) are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, statements related to expectations regarding future financial performance are forward-looking.

The company cautions that actual results may differ materially from those projected or implied in forward-looking statements due to a variety of important factors, including: fluctuations in customer demand for the company's products or services; unanticipated changes in business relationships with customers or their purchases from the company; weakness in global or regional general economic conditions and capital markets (as a result of financial stress affecting the banking system or otherwise); changes in customer demand or tariff rates and other costs associated with tariffs; the company's ability to effectively adjust prices for its products in response to changing dynamics; unplanned plant shutdowns; the rapidly evolving global regulatory landscape and the corresponding heightened operational complexity and compliance risks; the company's ability to maintain positive relations with unions and works councils; and the company's ability to complete and achieve the benefits of announced plans, programs, initiatives, divestitures, acquisitions, capital investments, and cost reduction actions. Additional factors are discussed in the company's filings with the Securities and Exchange Commission, including the company's Annual Report on Form 10-K for the year ended Dec. 31, 2025, quarterly reports on Form 10-Q and current reports on Form 8-K. Except as required by the federal securities laws, the company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Media Relations:

Sarah Factor

234.262.4878

[email protected]

Investor Relations:

Neil Frohnapple

234.262.2310

[email protected]

SOURCE The Timken Company

Share this article

Applications are open now for the career training and internship program in Providence; 20-year partnership with Citizens demonstrates employer's continued investment in local talent

- Applications are open now for Year Up United's Customer Experience career pathway in Providence, beginning October 19, 2026.

- The tuition-free pathway includes training in banking and customer success.

- Providence graduates in 2026 are earning an average of $25.04 per hour, and Citizens has provided internships to more than 400 Year Up United participants over 20 years.

BOSTON, Sept. 28, 2026 /PRNewswire/ -- For young adults looking to launch a meaningful career, getting a foot in the door can be one of the hardest steps, particularly as Rhode Island's job market shifts. Recent data from the Rhode Island Department of Labor and Training points to a changing workforce picture across the state: even as Rhode Island added jobs in August, 12,500 fewer residents were employed than a year ago and labor force participation continues to shrink. For young adults just starting out, building relevant skills, real-world experience and professional connections can be critical to getting a foothold.

Year Up United, the nation's leading workforce solutions partner, helps young adults without a bachelor's degree launch meaningful careers and helps employers build stronger, career-ready talent pipelines – creating pathways into careers for Rhode Islanders navigating that changing landscape. For alum Vannda Prak, that meant finding an alternative to what she had always viewed as the traditional path to success.

After transferring to community college and working in local restaurants while figuring out what she wanted her future to look like, Prak joined Year Up United's Providence program. She pursued the IT track and later interned with Citizens, where she gained experience and built professional connections that helped launch her career. Today, Prak is a Business Insights Analyst at Citizens.

"My career really started at Year Up United," said Prak. "In addition to the business knowledge and skills I gained during the program, it gave me things I never expected: drive, confidence, connection and hope for a brighter future that feels attainable."

In Providence, Year Up United prepares young adults for meaningful careers through training, coaching and real-world work experience, while working closely with employers to understand their evolving talent needs. Applications are open now for the Customer Experience pathway in Providence, which kicks off on October 19. The pathway includes training in banking, customer success, preparing participants for a range of customer-facing and operational roles.

"A changing job market doesn't mean young adults should wait to start building their careers. It makes preparing for opportunity even more important," said Susan Murray, Chief Executive Officer of Year Up United. "The skills, experience and relationships they build today can help them stand out, adapt as work changes and be ready when the right opportunity comes."

Year Up United participants are seeing strong outcomes locally. Providence graduates in 2026 are earning an average of $25.04 per hour, and in 2025, 76% of graduates were employed and/or enrolled in postsecondary education.

Employer partnerships help make those opportunities possible. This year, Year Up United is marking 20 years of partnership with Citizens, which has provided internships to more than 400 Year Up United participants since the organization opened its Providence location in 2005.

"Today's workforce requires adaptability, a commitment to continuously learn and access to meaningful opportunities for growth," said Susan La Monica, Chief Human Resources Officer at Citizens and Year Up United board member. "For more than 20 years, Citizens has partnered with Year Up United to help young adults develop professional skills, gain valuable experience and connect to career pathways that can change the trajectory of their future. We've seen firsthand how investing in people through mentorship, learning and career-connected experiences creates lasting opportunity for individuals while helping employers build the talent needed for the future."

For Rhode Island young adults considering their next step, applications are open now. Year Up United's Customer Experience program begins October 19. Learn more about eligibility and apply here.

About Year Up United:

Year Up United is the nation's leading workforce solutions partner, launching young adults without a bachelor's degree into meaningful careers and equipping employers with career-ready talent to create lasting economic mobility and impact at scale.

SOURCE Year Up United

Share this article

Chainlink Is Enabling Financial Institutions to Connect to Swift's Blockchain Ledger

MIAMI, Sept. 28, 2026 /PRNewswire/ -- Chainlink today announced it is working to enable financial institutions to connect their systems and key signing infrastructure to Swift's blockchain ledger through the Chainlink platform.

This solution enables banks to easily access the Swift ledger and manage their usage of smart contracts on both their own ledgers for tokenized deposits and the Swift ledger. At the center of the solution is a self-signing model for financial institutions enabled through the Chainlink Runtime Environment (CRE). Institutions retain control of the keys used to authorize transactions, while CRE orchestrates workflows connecting financial institutions to Swift's ledger. This enables banks to adopt 24/7 tokenized payment workflows while preserving their existing security governance, approval processes, and operating models.

Financial institutions will be able to use CRE to seamlessly connect to Swift's ledger, a digital platform for orchestrating 24/7 cross-border payments using tokenized deposits. These deposits live on bank-owned ledgers and securely coordinate the movement of funds between participating institutions, including overnight and weekends.

Swift's Ledger Enables Global Tokenized Payments

Swift's ledger provides a secure orchestration layer for 24/7 cross-border payments using tokenized deposits that remain on banks' balance sheets, thus preserving the benefits of commercial bank money. Bank-issued tokenized deposits remain on banks' own ledgers, while Swift's ledger securely coordinates the movement of funds between participating institutions, including overnight and on weekends.

This orchestration takes place before final settlement. Swift's ledger does not change Swift's role as a global financial messaging network, and final settlement continues through agreed mechanisms, such as real-time gross settlement systems. Banks can therefore extend payment availability without replacing their existing settlement arrangements.

"I'm very excited about the Swift ledger and what it will mean for tokenized deposits, as well as where global payments goes next. We are thrilled to be supporting the Swift ledger as more banks seek to join it and need a technology partner that can help them launch tokenized deposit capabilities and properly connect to the Swift ledger to gain the full benefit of its large network of users." Sergey Nazarov, CEO, Chainlink Labs

Swift announced its blockchain-based shared ledger at Sibos 2025. Designed in collaboration with more than 40 financial institutions from around the world, it went from concept to activation within nine months. Seventeen first-mover financial institutions are putting the ledger to first use by piloting tokenized deposit transactions for various use cases. Swift connects more than 11,500 financial institutions and corporates across more than 200 markets.

About Chainlink

Chainlink is the industry-standard on-chain finance platform bringing the capital markets onchain and the market leader powering the majority of DeFi. The Chainlink stack provides the essential data, interoperability, compliance, and privacy standards needed to power advanced blockchain use cases for institutional tokenized assets, lending, payments, stablecoins, and more. Since inventing decentralized oracle networks, Chainlink has enabled tens of trillions in transaction value and now secures the vast majority of DeFi.

Many of the world's largest financial services institutions have also adopted Chainlink's standards and infrastructure. Chainlink leverages a novel fee model where offchain and onchain revenue from enterprise adoption is converted to LINK tokens and stored in a strategic Chainlink Reserve. Learn more at chain.link.

SOURCE Chainlink

Share this article

The ISO/SAE 21434 standard defines rigorous engineering requirements for managing cybersecurity risk across the entire lifecycle of connected vehicles—from initial concept and hardware-software design through production, post-production operation, and decommissioning. Achieving certification with zero non-conformities confirms that Tensor's Cybersecurity Management System (CSMS) is aligned with the cybersecurity management requirements underlying UN Regulation No. 155 (UN R155), which governs cybersecurity type approval of vehicles across more than 60 countries, including the European Union, the United Kingdom, Japan, and South Korea.

"In the era of Physical AI, cybersecurity isn't just about protecting software—it's about safeguarding personal agency. While legacy automakers build connected vehicles that continuously stream data back to corporate clouds, the Tensor Robocar is engineered to answer solely to its owner. Completing the ISO/SAE 21434 audit with zero findings shows that our security-by-design processes are built to the standard the world's regulators expect – and that decentralized, onboard AI supercomputing can be developed with cybersecurity engineered in from the ground up."

— Dr. Jay Xiao, Founder & CEO of Tensor

Zero-Trust Security for Edge Physical AI

Unlike B2B commercial robotaxi fleets or cloud-dependent legacy EV architectures, the Tensor Robocar processes complex environmental perception, trajectory planning, and biometric authentication natively on the vehicle using its high-performance onboard supercomputing stack. The audit by Applus+ IDIADA covered the cybersecurity process governing Tensor's edge-first architecture, which is designed to operate without requiring persistent cloud connectivity.

Core Engineering Processes Audited:

- Lifecycle-Wide Security Engineering: Establishes traceability across every phase of vehicle development by requiring that every cybersecurity work product be uniquely identified, version-controlled, and traceable from top-level vehicle goals down to component requirements and verification tests.

- Rigorous Threat Analysis & Risk Assessment (TARA): Proves systemic threat coverage by conducting vehicle- and ECU-level TARAs with traceability between assets, threat scenarios, attack paths, risks, and controls using ISO/SAE 21434 methods.

- Vehicle Security Operations Center (VSOC): Operates an integrated Vehicle Security Operations Center with intrusion detection, tiered incident escalation, and defined response timelines for deployed vehicles.

- Secure Over-The-Air (OTA) Updates: Validates end-to-end software delivery integrity using Tensor's proprietary OTA platform to manage, deploy, and monitor firmware packages with complete cryptographic control.

- Multi-Layered Defensive Validation: Confirms empirical resilience through comprehensive penetration testing, fuzz testing, communication security testing, and static/dynamic code analysis directly linked to requirements derived from the TARA.

- Supply Chain Cybersecurity Governance: Applies a structured supplier evaluation framework covering governance, secure development practices, vulnerability management, incident support, evidence delivery, and change control to cybersecurity-relevant suppliers.

- Production & End-of-Line Verification: Prevents manufacturing-level vulnerabilities by extending cybersecurity requirements directly into vehicle flashing, provisioning, configuration, functional validation, and end-of-line testing prior to commercial release.

"Our assessment provided an independent evaluation of Tensor's cybersecurity processes against the requirements of ISO/SAE 21434, supporting a structured approach to automotive cybersecurity. Tensor has demonstrated compliance with the applicable requirements of the standard, and we look forward to continuing our collaboration in future activities."

— Alejandro Manilla, Applus+ IDIADA

Unlocking Global Expansion & Technology Licensing

The ISO/SAE 21434 certification marks a major milestone on Tensor's path to global markets, laying the groundwork for vehicle homologation and UN R155 type approval across Europe, the United Kingdom, South Korea, Japan and beyond. Tensor remains focused on delivering fully driverless capabilities wrapped in uncompromising digital and physical security.

Beyond the Tensor Robocar, Tensor has developed a licensable full-stack AI driving technology platform for automakers and Tier-1 suppliers. The ISO/SAE 21434 certification strengthens the cybersecurity foundation for that platform, demonstrating that the processes supporting its vehicle architecture, software, onboard computing, secure OTA updates, and vehicle security operations are aligned with the highest standards.

About Tensor

Tensor is an American Physical AI technology company developing agentic AI and full-stack autonomous driving technology. Its flagship product, the Tensor Robocar, is the world's first automotive-grade SAE Level 4 driverless vehicle built for both private ownership and robotaxi deployment. Beyond the Robocar, Tensor also licenses its full-stack Physical AI platform to automakers and Tier-1 suppliers through its Autonomous Driving as a Service (ADaaS) model.

Driven by Tensor's reasoning-capable agentic AI, the Robocar sets the standard of how Physical AI is transforming the way people interact with machines. The Robocar is about freedom, empowering users to choose between driving, or being driven, with a foldable steering wheel, retractable pedals, and a sliding display. Founded in Silicon Valley in 2016, Tensor has a global footprint spanning offices in San Jose, Barcelona, Singapore, and Dubai.

About Applus+ IDIADA

Applus+ IDIADA is a global partner to the automotive industry, offering design, engineering, testing, and homologation services. With over 30 years of experience and presence in 24 countries, IDIADA provides comprehensive technical support for international vehicle certification and regulatory compliance.

SOURCE Tensor Auto

Share this article

DALLAS, Sept. 28, 2026 /PRNewswire/ -- ATI Inc. (NYSE: ATI) will host an Investor Day livestream presentation from 12:30 PM to 3:00 PM ET on Thursday, November 12, 2026. ATI leaders will highlight the company's successful transformation, competitive advantages, profitable growth opportunities and new targets.

The event will be webcast live. For a link, go to the News & Events section of www.ATImaterials.com/investors. An audio replay and full transcript of the event will be available following the presentation.

ATI: Proven to Perform

ATI (NYSE: ATI) is a global producer of high-performance materials and solutions for the aerospace & defense markets, and specialty energy. We're solving the world's most difficult challenges through materials science. We partner with our customers to deliver extraordinary materials that enable their greatest achievements: their products fly higher and faster, burn hotter, dive deeper, stand stronger and last longer. Our proprietary process technologies, unique customer partnerships and commitment to innovation deliver materials and solutions for today and the evermore challenging environments of tomorrow. We are proven to perform anywhere. ATImaterials.com.

SOURCE ATI

Share this article